Back to Article
The Future of Longevity Medicine from the Lens of Digital Therapeutics
Journal of Artificial Intelligence and Big Data
| Vol 5, Issue 1
Table 1. Details of digital therapeutics in Longevity currently available in the market
| SlNo | Company Name & Country of Origin | Indication | Features |
| 1 | AgeX Therapeutics 16 United States | Regenerative Medicine | Specializes in regenerative medicine using pluripotent stem cells. Focused on tissue engineering and cell-based therapies. |
| 2 | Altos Labs 17 UK | Cellular Rejuvenation | Focuses on cellular rejuvenation programming to reverse age-related decline. High-profile team includes leading scientists and significant funding from Jeff Bezos. |
| 3 | Amazentis (Timeline) 18 Switzerland | Mitophagy & Muscle Health | Pioneers in research on mitophagy and mitochondrial health. Offers Urolithin A-based products for improving muscle and cell performance. |
| 4 | Apollo Health Ventures19 Germany | Aging Research Investment | Venture capital firm targeting companies with potential breakthroughs in aging. Supports translational research to bridge science and application. |
| 5 | BioAge Labs 20 United States | Aging Biomarker Discovery | Leverages human aging data to identify biomarkers and drug targets to combat aging-related diseases. |
| 6 | BioXtek21 United States | Regenerative Technology | Cutting-edge platform leverages the regenerative properties of amniotic membrane and other birth-derived tissues to address various age-related conditions. |
| 7 | Calico Labs22 United States | Aging-related Therapies | Backed by Google’s Alphabet, focused on understanding the biology of aging. Develops therapies targeting age-related diseases through collaboration with AbbVie. |
| 8 | Caristo Diagnostics23 Oxford, England | Cardiovascular aging | AI-based tool capable of predicting heart attacks up to a decade in advance by assessing coronary inflammation. This technology provides clinicians with a powerful tool to identify at-risk individuals and implement preventive measures. |
| 9 | CHARACTER BIOSCIENCES 24 USA | Disease Progression | Integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. |
| 10 | Chromadex (Tru Niagen) 25 United States | NAD+ Mitochondrial Health | Specializes in NAD+precursors to improve mitochondrial health. Products aimed at boosting energy and cellular repair. |
| 11 | Deep Longevity26 Hong Kong | AI for Biological Age | Builds AI-driven models to measure biological age and predict longevity based on health and lifestyle factors. |
| 12 | Dorian Therapeutics 27 USA | Senescence Therapies | They are developing senoblockers, a new class of therapeutics with a double function: blocking senescence while reactivating the regeneration capacity of a tissue. |
| 13 | Elysium Health28 United States | NAD+ Boosters & Aging | Offers consumer-facing products like NAD+ boosters and health supplements. Develops and 12commercializes epigenetic biomarkers for aging. |
| 14 | Glycan age29 UK | Biological Age Testing | Glycan Age is a simple, test that analyses glycobiology. Taking a GlycanAge® test is a vital step to determine once biological age. |
| 15 | Gero30 Singapore | Aging Biomarker Models | Develops AI-driven solutions to study biomarkers of aging and resilience. Known for predictive models of healthspan. |
| 16 | Insilico Medicine 31 Hong Kong | Aging Research | Combines AI with genomics to identify therapeutic targets for age-related diseases. Leader in using deep learning for drug discovery and aging research. |
| 17 | Juvenescence 32 United Kingdom | Aging-related Diseases | A biotech company investing in and developing drugs to target aging and age-related conditions. Broad portfolio includes senolytics and metabolic regulators. |
| 18 | Libella Gene Therapeutics 33 United States | Telomere Lengthening | Focused on telomere lengthening through gene therapy. Clinical trials for aging-related diseases are underway. |
| 19 | Life Biosciences 34 United States | Cellular Health Aging | Aims to combat aging through research in epigenetics, mitochondrial health, and senescence. Focuses on restoring cellular health to extend lifespan. |
| 20 | Longevity Vision Fund 35 United States | Aging & Longevity Investment | Focuses on funding startups in aging and longevity science. Invests in innovations targeting healthspan and lifespan extension. |
| 21 | MICREGEN 36 UK | Stem Cell Therapies | Innovative approach in developing the Secretomix® platform to produce various secretome formulations from its first clinical grade master and working cell banks, could change how multiple critical and chronic problems are managed- not just the symptoms, but the root causes of diseases. They are primarily working on stem cells. |
| 22 | ONE SKIN 37 USA | Skin Aging Reversal | Their products focus on skin longevity. One Skin’s proprietary peptide, OS-01, is an ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. |
| 23 | Oisín Biotechnologies 38 USA | Aging-related diseases | Longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear the senescent cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival. |
| 24 | PULSE SIGHT 39 France | Age-related Macular Degeneration | Ophthalmology drug development company developing disruptive non-viral gene therapies with minimally invasive delivery technology to treat AMD. |
| 25 | Rejuvenate Bio 40 United States | Gene Therapy Aging | Utilizes gene therapy to reverse age-related conditions in animals and humans. Targeting cardiovascular and metabolic diseases. |
| 26 | SUZHOU Ruiming41 China | Age-related Macular Degeneration | The company has developed an eye-drop drug delivery technology for fundus diseases which include age-related wet macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema. |
| 27 | S-Biomedic 42 Belgium | Skin Health Solutions | Focused on skin health by pioneering the development of Pro- and Post-biotic ingredients from true skin commensals. |
| 28 | SeaBeLife Biotech 43 France | Neurodegenerative diseases | Focuses on the development of molecules designed to block regulated necrosis – also known as regulated cell death. |
| 29 | Sirona Biochem Corp 44 Canada | Skin Health Solutions | Developed a novel anti-aging compound designed to reverse the effects of aging on facial skin. |
| 30 | Thorne HealthTech 45 United States | Personalized Longevity | Provides personalized health insights through testing kits. Focuses on nutritional solutions and longevity interventions. |
| 31 | Turn Biotechnologies 46 United States | Epigenetic Reprogramming | Uses epigenetic reprogramming to restore youthful cell function. Targets applications in skin and muscle rejuvenation. |
| 32 | Unity Biotechnology 47 United States | Senolytic Therapies | Focuses on eliminating senescent cells to address diseases like osteoarthritis, fibrosis, and neurodegenerative conditions. |